October 2007. Volume 3. Number 3

Invasive pneumococcal disease: increase of incidence caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Singleton RJ, Hennessy TW, Bulkow LR, Hanmit LL, Zulz T, Hurburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-92
Reviewers: Ruiz-Canela Cáceres J1, Juanes de Toledo B2.
1 Distrito Sanitario Sevilla. España.
2 Equipo de Atención Primaria El Espinillo. Área-11. Madrid. España.
Correspondence: Juan Ruiz-Canela Cáceres. Email: jruizc@aepap.org
Reception date: 8/08/2007
Acceptance date: 13/08/2007
Publication date: 01/09/2007

Abstract

How to cite this article

Ruiz-Canela Caceres J, Juanes de Toledo B. Enfermedad Neumocócica Invasiva: Aumento de la incidencia de serotipos no vacunales tras la vacunación universal de los niños nativos de Alaska. Evid Pediatr. 2007;3:74.

AVC | Critically appraised articles

Singleton RJ, Hennessy TW, Bulkow LR, Hanmit LL, Zulz T, Hurburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-92
Reviewers: Ruiz-Canela Cáceres J1, Juanes de Toledo B2.
1 Distrito Sanitario Sevilla. España.
2 Equipo de Atención Primaria El Espinillo. Área-11. Madrid. España.
Correspondence: Juan Ruiz-Canela Cáceres. Email: jruizc@aepap.org
Reception date: 8/08/2007
Acceptance date: 13/08/2007
Publication date: 01/09/2007

How to cite this article

Ruiz-Canela Caceres J, Juanes de Toledo B. Enfermedad Neumocócica Invasiva: Aumento de la incidencia de serotipos no vacunales tras la vacunación universal de los niños nativos de Alaska. Evid Pediatr. 2007;3:74.

References

  1. Peters T R, Poehling K. Invasive pneumococcal disease, the target is moving. JAMA. 2007;297:1825-6.
  2. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec. 2007;82:93-104.
  3. Barricarte A, Castilla,J , Gil-Setas A, Torroba L, Antonio Navarro-Alonso J, Irisarri F, et al. Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Case-Control Study. Clin Infect Dis. 2007;44:1436-41.
  4. Kaplan SL, Mason EO, Wald ER, Schutze GE, Bradley JS, Tan TQ, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113:443-9.
  5. Barricarte A, Gil-Setas A, Torroba L, Castilla J, Petit A, Polo I, et al. Enfermedad neumocócica invasiva en la población menor de 5 años de edad de Navarra (2000-2005): impacto de la vacuna conjugada. Med Clin (Barc). 2007;129:41-5.
  6. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J,et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26:468-72.
01/09/2007

Linked Comment